Lipitor Ruling Could Affect Other Patent Cases, Experts Say

Drug Industry Daily
KEYWORDS courts / generic / Patents

If a U.S. court strikes down Pfizer’s formulation patent for Lipitor, like a British court did this week, it could set a bad precedent for other drugs such as Lexapro and Plavix that are facing U.S. challenges to the same kind of patents.

To View This Article:


Subscribe To Drug Industry Daily